The linear chromosomes ends in eukaryotes are protected by telomeres, a nucleoprotein structure that contains telomeric DNA with repetitive sequence and associated proteins. Telomerase is an RNA-dependent DNA polymerase that adds telomeric DNA repeats to the 3'-ends of chromosomes to offset the loss of terminal DNA repeats during DNA replication. It consists of two core components: a telomerase reverse transcriptase (TERT) and a telomerase RNA (TR). Telomerase uses a short sequence in its integral RNA component as template to add multiple DNA repeats in a processive manner. However, it remains unclear how the telomerase utilizes the short RNA template accurately and efficiently during DNA repeat synthesis. As previously reported human telomerase nucleotide synthesis arrests upon reaching the end of its RNA template by a unique template-embedded pause signal. In this study, I demonstrate pause signal remains active following template regeneration and inhibits the intrinsic processivity and rate of telomerase repeat addition. Furthermore, I have found that the human telomerase catalytic cycle comprises a crucial and slow incorporation of the first nucleotide after template translocation. This slow nucleotide incorporation step drastically limits repeat addition processivity and rate, which is alleviated with elevated concentrations of dGTP. Additionally, molecular mechanism of the disease mutants on telomerase specific motif T, K570N, have been explored. Finally, I studied how telomerase selective inhibitor BIBR 1532 reduce telomerase repeat addition processivity by function assay. Together, these results shed new light on telomerase catalytic cycle and the importance of telomerase for biomedicine.